These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36690124)

  • 1. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
    Patel D; Brown ML; Edwards S; Oster RA; Stripling J
    Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
    Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
    Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
    Yi YH; Wang JL; Yin WJ; Xu WH
    Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ; Barber KE; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia.
    García P; Moscoso M; Fernández MC; Fuentes-Valverde V; Pérez A; Bou G
    Int J Antimicrob Agents; 2023 Jul; 62(1):106836. PubMed ID: 37150362
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Davis KP; McDermott LA; Snydman DR; Aldridge BB
    Microbiol Spectr; 2024 Aug; 12(8):e0097624. PubMed ID: 38916355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Cohort of Patients With Methicillin-Resistant
    McCreary EK; Kullar R; Geriak M; Zasowski EJ; Rizvi K; Schulz LT; Ouellette K; Vasina L; Haddad F; Rybak MJ; Zervos MJ; Sakoulas G; Rose WE
    Open Forum Infect Dis; 2020 Jan; 7(1):ofz538. PubMed ID: 31938716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
    Morrisette T; Lagnf AM; Alosaimy S; Rybak MJ
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2199-2203. PubMed ID: 32535805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
    Kunz Coyne AJ; Stamper K; Bleick C; Kebriaei R; Lehman SM; Rybak MJ
    Microbiol Spectr; 2024 Apr; 12(4):e0321223. PubMed ID: 38411110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant
    Hornak JP; Anjum S; Reynoso D
    Ther Adv Infect Dis; 2019; 6():2049936119886504. PubMed ID: 31857898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
    J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
    Tsai CE; Yang CJ; Chuang YC; Wang JT; Sheng WH; Chen YC; Chang SC
    Int J Infect Dis; 2022 Sep; 122():230-236. PubMed ID: 35640827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
    Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
    Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
    Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
    Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant
    Huang C; Chen I; Lin L
    Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.